Vanessa DeBruin

1.7k total citations
10 papers, 63 citations indexed

About

Vanessa DeBruin is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Economics and Econometrics. According to data from OpenAlex, Vanessa DeBruin has authored 10 papers receiving a total of 63 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 4 papers in Economics and Econometrics. Recurrent topics in Vanessa DeBruin's work include Blood Pressure and Hypertension Studies (8 papers), Hemodynamic Monitoring and Therapy (3 papers) and Economic and Environmental Valuation (2 papers). Vanessa DeBruin is often cited by papers focused on Blood Pressure and Hypertension Studies (8 papers), Hemodynamic Monitoring and Therapy (3 papers) and Economic and Environmental Valuation (2 papers). Vanessa DeBruin collaborates with scholars based in United States, Germany and Greece. Vanessa DeBruin's co-authors include David E. Kandzari, Michael A. Weber, Felix Mahfoud, Martin Fahy, Raymond R. Townsend, Sandeep Brar, Kazuomi Kario, Stuart Pocock, Graeme L. Hickey and Michael Böhm and has published in prestigious journals such as Journal of the American College of Cardiology, Hypertension and American Heart Journal.

In The Last Decade

Vanessa DeBruin

10 papers receiving 62 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vanessa DeBruin United States	4	51	16	15	12	11	10	63
Jill Barton United Kingdom	4	41 0.8×	15 0.9×	8 0.5×	9 0.8×	6 0.5×	6	86
Priscilla Pemu United States	4	67 1.3×	14 0.9×	22 1.5×	5 0.4×	3 0.3×	8	95
Neal K. Lakdawala United States	3	81 1.6×	8 0.5×	22 1.5×	5 0.4×	3 0.3×	7	110
Carl Abbott United States	4	51 1.0×	10 0.6×	13 0.9×	24 2.0×		8	95
Antonia Villar-Ráez Spain	4	91 1.8×	16 1.0×	41 2.7×	9 0.8×	4 0.4×	7	176
Taishi Dotare Japan	7	47 0.9×	10 0.6×	15 1.0×	20 1.7×	1 0.1×	14	123
Lisa Claude United States	3	32 0.6×	10 0.6×	10 0.7×	14 1.2×	6 0.5×	3	36
Erik Riessen United States	2	61 1.2×	16 1.0×	5 0.3×	5 0.4×	3 0.3×	2	72
Luiz Cláudio Danzmann Brazil	7	127 2.5×	17 1.1×	3 0.2×	21 1.8×	4 0.4×	29	164
Oana-Florentina Tautu Romania	5	59 1.2×	16 1.0×	12 0.8×	8 0.7×	1 0.1×	8	98

Countries citing papers authored by Vanessa DeBruin

Since Specialization

Citations

This map shows the geographic impact of Vanessa DeBruin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa DeBruin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa DeBruin more than expected).

Fields of papers citing papers by Vanessa DeBruin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa DeBruin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa DeBruin. The network helps show where Vanessa DeBruin may publish in the future.

Co-authorship network of co-authors of Vanessa DeBruin

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa DeBruin. A scholar is included among the top collaborators of Vanessa DeBruin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa DeBruin. Vanessa DeBruin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Kandzari, David E., Felix Mahfoud, Raymond R. Townsend, et al.. (2025). Long-Term Safety and Efficacy of Renal Denervation: 24-Month Results From the SPYRAL HTN-ON MED Trial. Circulation Cardiovascular Interventions. 18(7). e015194–e015194. 1 indexed citations

Sharp, Andrew, David E. Kandzari, Raymond R. Townsend, et al.. (2024). A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study. Cardiovascular revascularization medicine. 68. 30–36. 1 indexed citations

Mahfoud, Felix, David Kandzari, Kazuomi Kario, et al.. (2024). TCT-481 Renal Artery Imaging Through Long-Term Follow-up Following Radiofrequency Renal Denervation: Results From the SPYRAL Clinical Trial Program. Journal of the American College of Cardiology. 84(18). B157–B157. 1 indexed citations

Pathak, Atul, Michael A. Weber, Christine Poulos, et al.. (2022). Patients’ Tolerance for Risks Associated With Interventional or Pharmaceutical Hypertension Treatment: Results From a Discrete Choice Experiment Study. Cardiovascular revascularization medicine. 40. 66–66. 1 indexed citations

Pathak, Atul, Michael Weber, Christine Poulos, et al.. (2022). PATIENT PREFERENCES FOR PHARMACEUTICAL AND INTERVENTIONAL HYPERTENSION TREATMENTS: RESULTS FROM A DISCRETE CHOICE EXPERIMENT. Journal of Hypertension. 40(Suppl 1). e56–e56. 1 indexed citations

Weber, Thomas, Siegfried Wassertheurer, Christopher Mayer, et al.. (2022). Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial. Hypertension. 79(7). 1506–1514. 11 indexed citations

Kandzari, David E., Michael A. Weber, Christine Poulos, et al.. (2022). Patient Preferences for Pharmaceutical and Device-Based Treatments for Uncontrolled Hypertension: Discrete Choice Experiment. Circulation Cardiovascular Quality and Outcomes. 16(1). e008997–e008997. 12 indexed citations

Böhm, Michael, Martin Fahy, Graeme L. Hickey, et al.. (2021). A re-examination of the SPYRAL HTN-OFF MED Pivotal trial with respect to the underlying model assumptions. Contemporary Clinical Trials Communications. 23. 100818–100818. 6 indexed citations

Böhm, Michael, Raymond R. Townsend, Kazuomi Kario, et al.. (2020). Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design. Clinical Research in Cardiology. 109(3). 289–302. 26 indexed citations

10.

Waksman, Ron, George L. Bakris, Arie Steinvil, et al.. (2017). High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3. American Heart Journal. 192. 76–84. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact